Accessing GLP-1 treatment in Redwood City, California has traditionally meant longer waits than mainland patients face. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Redwood City address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Redwood City is already seeing results
Rybelsus in Redwood City, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Redwood City from $199/month with virtual consultations and direct-to-door shipping.
For many people in Redwood City, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk, approved in 2019 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Redwood City.
Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Redwood City, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.